These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11115448)

  • 1. Use of intraoperative hetastarch priming during coronary bypass.
    Canver CC; Nichols RD
    Chest; 2000 Dec; 118(6):1616-20. PubMed ID: 11115448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery?
    Knutson JE; Deering JA; Hall FW; Nuttall GA; Schroeder DR; White RD; Mullany CJ
    Anesth Analg; 2000 Apr; 90(4):801-7. PubMed ID: 10735779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial.
    Hecht-Dolnik M; Barkan H; Taharka A; Loftus J
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):703-11. PubMed ID: 19698859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations.
    Cope JT; Banks D; Mauney MC; Lucktong T; Shockey KS; Kron IL; Tribble CG
    Ann Thorac Surg; 1997 Jan; 63(1):78-82; discussion 82-3. PubMed ID: 8993245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study.
    Gurbuz HA; Durukan AB; Salman N; Tavlasoglu M; Durukan E; Ucar Hİ; Yorgancioglu C
    J Cardiothorac Surg; 2013 Apr; 8():71. PubMed ID: 23566712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
    London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting.
    Gallagher JD; Moore RA; Kerns D; Jose AB; Botros SB; Flicker S; Naidech H; Clark DL
    Anesth Analg; 1985 Aug; 64(8):753-8. PubMed ID: 2409845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
    Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
    J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
    Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?
    Boks RH; Wijers MJ; Hofland J; Takkenberg JJ; Bogers AJ
    Perfusion; 2007 Sep; 22(5):333-7. PubMed ID: 18416219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of autologous blood as part of the perfusate for cardiopulmonary bypass: a priming technique.
    Myers GJ; Legare JF; Sullivan JA; Leadon RB; Johnstone R; Swyer W; Squires C; Power C; Hirsch GM
    Perfusion; 2002 May; 17(3):211-6. PubMed ID: 12017390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?
    Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery.
    Scott DA; Hore PJ; Cannata J; Masson K; Treagus B; Mullaly J
    Perfusion; 1995 Nov; 10(6):415-24. PubMed ID: 8747898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass.
    Sade RM; Crawford FA; Dearing JP; Stroud M
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):35-8. PubMed ID: 6177973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding hetastarch to the adult cardiopulmonary bypass prime does not affect patient outcomes.
    Boykin MP; Ecklund JM; Riley JB; McCall MM
    J Extra Corpor Technol; 1997 Mar; 29(1):25-9. PubMed ID: 10166362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.
    Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL
    Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair.
    Marik PE; Iglesias J; Maini B
    J Crit Care; 1997 Jun; 12(2):51-5. PubMed ID: 9165412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
    Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL
    Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.